Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
NCT06885905 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-03-20
Summary
To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.
Conditions
- Chronic Pulmonary Aspergillosis
Sponsors & Collaborators
-
Manchester University NHS Foundation Trust
collaborator OTHER_GOV -
Tayside Medical Science Centre
collaborator OTHER -
Imperial College London
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-27
- Primary Completion
- 2025-08-23
- Completion
- 2026-04-23
Countries
- United Kingdom
Study Locations
More Related Trials
-
Risk of Aspergillus Infection in Patients With Chronic Lung Disease
NCT06379568 ·Status: COMPLETED
-
Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA)
NCT00906568 ·Status: COMPLETED
-
Health Impact of Non-Tuberculous Mycobacteria Pulmonary Disease (NTM-PD)
NCT07192705 ·Status: RECRUITING
-
Longitudinal Assessment of Clinical Course and BIOmarkers in Severe Chronic AIRway Disease
NCT00555607 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis, Utilisation of Health Care Resources in Patients With COPD
NCT01245933 ·Status: COMPLETED
-
Impact of A. Lumbricoides on Pulmonary Aspergillosis Development
NCT05783544 ·Status: RECRUITING ·Phase: NA
-
Allergic Bronchopulmonary Aspergillosis Prescreening Study
NCT05903612 ·Status: WITHDRAWN
-
Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria
NCT03594032 ·Status: UNKNOWN
-
Pattern of Microbial Infection in AECOPD Patients and Its Sensitivity to Antibiotics
NCT06123780 ·Status: NOT_YET_RECRUITING
-
Michigan Early Disease Progression Cohort
NCT04968249 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis
NCT07313904 ·Status: RECRUITING
-
Heterogeneity and Development of Early COPD
NCT06096285 ·Status: RECRUITING
-
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF
NCT01874223 ·Status: COMPLETED
-
Mitigating Chronic Respiratory Disease Through the Lens of Multi-Morbidity
NCT07050823 ·Status: RECRUITING
-
Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
NCT07040332 ·Status: RECRUITING
-
Is COPD a Risk Factor for Cardiovascular Disease?
NCT02162095 ·Status: COMPLETED
-
The Characteristic of Airway Microbiome Profiling of COPD-bronchiectasis Overlap Patients and Its Association With Acute Exacerbation
NCT04865861 ·Status: UNKNOWN
-
Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK
NCT02468271 ·Status: COMPLETED
-
Cytokine Profile of Allergic Bronchopulmonary Aspergillosis
NCT03643185 ·Status: UNKNOWN
-
Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life
NCT01423071 ·Status: COMPLETED
-
The MRC/ABPI COPD Cohort v1.7
NCT01620645 ·Status: UNKNOWN
-
Markers for Chronic Obstructive Pulmonary Disease (COPD)
NCT00180622 ·Status: WITHDRAWN
-
Symptom Clusters and Immune Markers in Patients With Chronic Obstructive Pulmonary Disease (COPD) - a Longitudinal Study
NCT01016587 ·Status: COMPLETED
-
Investigating the Clinical Features and Prognosis of Bronchiectasis Adult Patients
NCT04987827 ·Status: UNKNOWN
-
Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01007734 ·Status: COMPLETED